4.6 Review

Mitophagy and Neuroprotection

Journal

TRENDS IN MOLECULAR MEDICINE
Volume 26, Issue 1, Pages 8-20

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2019.07.002

Keywords

-

Funding

  1. HELSE SoR-OST [2017056]
  2. Research Council of Norway [262175, 277813]
  3. Akershus University Hospital Strategic grant [269901]
  4. AXA Research Fund post-doctoral long-term fellowship
  5. Hellenic Foundation for Research and Innovation (HFRI)
  6. General Secretariat for Research and Technology (GSRT)
  7. European Research Council [ERC GA695190 - MANNA]
  8. European Commission Framework Programmes
  9. Greek Ministry of Education

Ask authors/readers for more resources

Neurodegenerative diseases are strongly age-related and currently cannot be cured, with a surge of patient numbers in the coming decades in view of the emerging worldwide ageing population, bringing healthcare and socioeconomic challenges. Effective therapies are urgently needed, and are dependent on new aetiological mechanisms. In neurons, efficient clearance of damaged mitochondria, through the highly evolutionary conserved cellular process termed mitophagy, plays a fundamental role in mitochondrial and metabolic homeostasis, energy supply, neuronal survival, and health. Conversely, defective mitophagy leads to accumulation of damaged mitochondria and cellular dysfunction, contributing to ageing and age-predisposed neurodegeneration. Here, we discuss the contribution of defective mitophagy in these diseases, and underlying molecular mechanisms, and highlight novel therapeutics based on new discovered mitophagy-inducing strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available